roam/20211218153700-hormonal_treatment_strategies_tailored_to_non_binary_transgender_individuals.org

Hormonal treatment strategies tailored to non-binary transgender individuals

This paper suggests that erectile function can be retained in a Feminizing hormone therapy regimen using estrogen monotherapy or with low doses of CPA.

AMAB individuals requesting full feminization (i.e., breast development, body composition, skin tenderness) and preservation, at the same time, of erectile function can benefit from only-estrogens treatment or estrogens combined with low dosages of cyproterone acetate (10mg/daily or 25 mg on alternative days) or with 5α-reductase inhibitors